RA
KRMD icon

Royce & Associates’s KORU Medical Systems KRMD Stock Holding History

Royce & Associates’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-64,400
Closed -$193K – 995
2021
Q4 		$193K Sell
64,400
-154,500
-71% -$474K ﹤0.01% 948
2021
Q3 		$624K Buy
218,900
+25,600
+13% +$84.7K ﹤0.01% 869
2021
Q2 		$895K Buy
193,300
+91,100
+89% +$358K 0.01% 857
2021
Q1 		$360K Buy
102,200
+46,652
+84% +$202K ﹤0.01% 970
2020
Q4 		$334K Buy
+55,548
New +$311K ﹤0.01% 929
2020
Q3 		– Sell
-1,284
Closed -$12K – 1083
2020
Q2 		$12K Buy
+1,284
New +$13K ﹤0.01% 1129

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
AFG
Albion Financial Group Salt Lake City, Utah $1.55B AUM 19.86% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

Royce & Associates's KRMD Position: Q1 2022 in Review

Royce & Associates sold out of KORU Medical Systems (KRMD) in Q1 2022, closing a stake of 64,400 shares — an estimated $193K sold.

Royce & Associates first reported a position in KRMD in Q2 2020 and held it in 6 quarters. The position peaked at $895K in Q2 2021. 36 funds tracked by Wall St. Rank hold KRMD as of Q1 2022.

  • Royce & Associates reported no remaining KORU Medical Systems position as of Q1 2022 after selling out during the quarter.
  • Royce & Associates sold 64,400 KORU Medical Systems shares in Q1 2022, an estimated $193K.
  • Royce & Associates first reported a position in KORU Medical Systems in Q2 2020 and held it in 6 quarters.
  • Royce & Associates's KORU Medical Systems position peaked at $895K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2022.

Based on Royce & Associates's 13F filing for Q1 2022, filed 5 May 2022.